Brief: Vivoryon Therapeutics Completes Listing Of 2.1 Mln Shares
23/11/2022 06:03
Nov 23 (Reuters) - Vivoryon Therapeutics NV 05Y.F :
* SUCCESSFUL LISTING OF 2,054,796 SHARES
* LISTING COMPLETED AFTER PRIVATE PLACEMENT REALIZING
INVESTMENT
OF EUR 15 MILLION IN COMPANY FOR DEVELOPMENT OF VAROGLUTAMSTAT
IN ALZHEIMER'S DISEASE
Source text for Eikon: ID:nEQ6M5RYa
Further company coverage: 05Y.F
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Vivoryon Therapeutics NV
See all newsEurope Research Roundup: Colonial, Covivio SA, Fluidra SA
Brief: Vivoryon Therapeutics Says VIVIAD Phase 2B Study Does Not Meet Primary Endpoints
Brief: Vivoryon Reports Positive Outcome To Proceed With Alzheimer Drug Study
Jefferies starts Vivoryon at 'buy' on positive risk/reward from Alzheimer's pill
Brief: Vivoryon Therapeutics Announces Proposed Appointment Of Frank Weber As Chief Executive Officer